Case Reports

Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinib

The Ohio State University James Comprehensive Cancer Center, Department of Internal Medicine, Division of Hematology/Medical Oncology
The Ohio State University Wexner Medical Center, Department of Dermatology
The Ohio State University Wexner Medical Center, Department of Pathology
The Ohio State University James Comprehensive Cancer Center
The Ohio State University James Comprehensive Cancer Center; The Ohio State University Biomedical Sciences Graduate Program
The Ohio State University James Comprehensive Cancer Center
The Ohio State University James Comprehensive Cancer Center
The Ohio State University James Comprehensive Cancer Center, Department of Internal Medicine, Division of Hematology/Medical Oncology
The Ohio State University James Comprehensive Cancer Center, Department of Internal Medicine, Division of Hematology/Medical Oncology
The Ohio State University James Comprehensive Cancer Center
The Ohio State University James Comprehensive Cancer Center
Foundation Medicine Inc.
Foundation Medicine Inc.
The Ohio State University Wexner Medical Center, Department of Pathology
The Ohio State University Wexner Medical Center, Department of Pathology; The Ohio State University James Comprehensive Cancer Center; The Ohio State University Biomedical Sciences Graduate Program
The Ohio State University Wexner Medical Center, Department of Pathology
The Ohio State University James Comprehensive Cancer Center, Department of Internal Medicine, Division of Medical Oncology
Vanderbilt University Medical Center, Department of Internal Medicine, Division of Hematology/Oncology
Haematologica Early view May 30, 2024 https://doi.org/10.3324/haematol.2024.285146